BMY vs RTX · P/E 17, rev $24.46B vs P/E 36, rev $46.78B
Bristol-Myers Squibb Company (BMY) versus RTX Corporation (RTX) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported RTX revenue for 2026-06-30 was $46.78B. Net income was $4.20B. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Not investment advice. Open the BMY and RTX stock pages for the full models.
Not investment advice.